Difference between revisions of "Anatomic Pathology Work Group"
| Line 226: | Line 226: | ||
=== Files/Links for Review === | === Files/Links for Review === | ||
| − | Draft M&C v3 for review [http://wiki.hl7.org/images/ | + | Draft M&C v3 for review [http://wiki.hl7.org/images/f/f9/AP_WG_M%26C_v3.1.docx] |
Draft minutes from latest conference call [http://wiki.hl7.org/images/7/7b/AP_WG_CC_7-23-2014-draft.docx] | Draft minutes from latest conference call [http://wiki.hl7.org/images/7/7b/AP_WG_CC_7-23-2014-draft.docx] | ||
Revision as of 16:45, 20 January 2015
Contents
Mission
The mission of the Anatomic Pathology WG is to develop and review implementation guides of HL7 standards and to enhance existing HL7 standards to support anatomic pathology use cases. It will work within HL7 as well as with external organizations to facilitate information interoperability in anatomic pathology, such as:
- Tracking of anatomic pathology specimens
- Structuring and coding of anatomic reports
- Integrating and consolidating anatomic pathology data and other data into the medical record (e.g. integrated composite reports)
- Ensuring consistency of anatomic pathology data and corresponding image association (includes both radiology and pathology imaging)
- Reviewing previously defined terms that differ between organizations (e.g. What is a “specimen”)
- Developing/reviewing value sets as needed (e.g. DICOM Specimen Embedding Media)
- Collecting and sharing data from biorepositories/tissue banks
Charter
The basic charter of the Anatomic Pathology work group is to initially support the development and implementation of Version 2.x and CDA. Use cases and/or implementation guides brought to the group for review that include Version 3.0 will be addressed on an individual basis. Since the mission of the group is to review existing implementation guides/profiles and recommend changes as needed, as opposed to creating entirely new standard definitions, most work will focus on use case or organization specific needs.
Current Agenda for January 2015 WG Meeting
Legend
- business
- ballot reconciliation
- technical- / = joint session
- + = session with representatives of
| Date | Quarter | Icon | Event | Chair | Scribe | Room | ||
| Monday, September 15 | Q1 | No meeting | ||||||
| Q2 | No meeting | |||||||
| Q3 | No meeting | |||||||
| Q4 | No meeting | |||||||
| . | ||||||||
| Tuesday, September 16 | Q1 | 
|
Group business (DMP, project status, etc.) | |||||
| Q2 | 
|
IHE and DICOM updates and related projects (specimen, workflow) | ||||||
| Q3 |
|
Joint with CG (AP hosting), Joint projects around specimen mode, AP/molecular workflow, and IOM efforts | ||||||
| Q4 |
|
Wrap-up, next steps | ||||||
| . | ||||||||
| Wednesday, September 17 | Q1 | No meeting | ||||||
| Q2 |
|
Joint with O&O | ||||||
| Q3 | No meeting | |||||||
| Q4 | No meeting | |||||||
| . | ||||||||
| Thursday, September 18 | Q1 | No meeting | ||||||
| Q2 | No meeting | |||||||
| Q3 | No meeting | |||||||
| Q4 | No meeting | |||||||
| . | ||||||||
| Friday, September 19 | Q1 |
No Meeting |
||||||
| Q2 |
No Meeting |
|||||||
| Q3 | No Meeting | |||||||
| Q4 | No Meeting |
Past Agendas
Agenda for San Diego, 2011
Agenda for San Antonio, 2012
Agenda for Vancouver, BC 2012
Agenda for Baltimore, 2012
Agenda for Scottsdale, January 2013
Agenda for Atlanta, May 2013
Temporary Contents
Files/Links for Review
Draft M&C v3 for review [1]
Draft minutes from latest conference call [2]
Sample APSR from HL7 Germany [3]
Companion text for the above APSR [4]
May 2104 WGM Minutes for Review [5]
JD's DICOM talk [6]
DICOM AP Workflows [7]
CAP Cancer Biomarker Project [8]
Draft SWOT [9]
Draft WGM Minutes for review (Sept 2013 WGM) [10]
Draft DMP for review [11]
Trello Concept
Trello Board [12]
HL7 Germany Work on Lab Specimen Reports
Original Work (in German) [13]
English translation [14]
Latest Version of Ballot
Latest Ballot Comments
Update 20120628: Updated Spec ID doc
